Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

global access

- PMLiVE

Merck & Co inches closer to US green light for insomnia drug

FDA panel backs suvorexant, although some concerns about high dosages

- PMLiVE

Clinical trial regulation in Mexico

Regulatory improvements make Mexico an appealing destination for clinical trials outsourcing

- PMLiVE

GSK awarded $200m by US government for antibiotic research

Follows state-supported schemes in Europe to combat resistance to antibiotics

- PMLiVE

Clare Gerada to step down as UK RCGP chair

Maureen Baker nominated as chair-elect

- PMLiVE

David Nicholson to step down as head of England’s NHS

Decision to retire comes two months after publication of Francis report into hospital scandal

- PMLiVE

Roche repeats cancer drugs warning as Avastin faces another NICE rejection

Concerns about future of Cancer Drugs Fund

- PMLiVE

Italian pharma market set for continued downturn

Will fall $1.6bn in value by 2020, says analyst GlobalData

- PMLiVE

Novartis wins third NICE recommendation for Lucentis

Gains final backing to treat NHS patients with macular oedema

- PMLiVE

Health editor at The Sun newspaper joins Ruder Finn

Emma Morton appointed media strategist at PR firm

- PMLiVE

Informational source shift: from marketing to medical

The changing role of medical information in HCP communications pathways

- PMLiVE

France ignores EMA and suspends Bayer’s Diane 35

National Agency for the Safety of Drugs and Health Products contradicts PRAC verdict

ClinTec International expands into Turkey

CRO says new office will bolster its presence in the Middle East and North Africa

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links